582 reports of this reaction
2.7% of all LOPERAMIDE HYDROCHLORIDE ORAL reports
#6 most reported adverse reaction
FATIGUE is the #6 most commonly reported adverse reaction for LOPERAMIDE HYDROCHLORIDE ORAL, manufactured by AMERISOURCE BERGEN. There are 582 FDA adverse event reports linking LOPERAMIDE HYDROCHLORIDE ORAL to FATIGUE. This represents approximately 2.7% of all 21,604 adverse event reports for this drug.
Patients taking LOPERAMIDE HYDROCHLORIDE ORAL who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for LOPERAMIDE HYDROCHLORIDE ORAL, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for LOPERAMIDE HYDROCHLORIDE ORAL:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 582 FDA reports for LOPERAMIDE HYDROCHLORIDE ORAL. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.7% of all adverse event reports for LOPERAMIDE HYDROCHLORIDE ORAL, making it a notable side effect.
If you experience fatigue while taking LOPERAMIDE HYDROCHLORIDE ORAL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.